Northwest Biotherapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Northwest Biotherapeutics Inc.

NWBO 0.270

-5.3%

10:25 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (51)	8/22/2006 5:16:39 PM
From: zeta1961	Read Replies (1) of 760

John, any ideas re: which company they are talking about in the bolded section(mine)..fwiw, MD Anderson will be among my my first phone calls if I am diagnosed with the big C..although I think it highly unlikely that I will subject myself to chemo or the targeted therapies..been there, done that..either with my own childhood CA or my beloved's.. Glioblastoma Another solid tumor -- one that is even more treacherous than melanoma -- appears to respond to a novel vaccine being developed and tested at M. D. Anderson. This vaccine significantly increased life expectancy in patients with glioblastoma multiforme (GBM), the most dangerous type of brain tumor. The results were so surprising that the trial was stopped before full accrual, and a pharmaceutical company acquired the rights to the drug. A larger, multi- institutional, randomized study is being planned, says Amy Heimberger, M.D., an assistant professor of Neurosurgery who led the trial, conducted at both M. D. Anderson and at Duke University Medical Center.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next